Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
5,138,616
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
30,251
-
Shares change
-
+13,572
-
Total reported value, excl. options
-
$80,464
-
Value change
-
+$34,765
-
Number of buys
-
5
-
Number of sells
-
4
-
Price
-
$2.66
Institutional Holders of RedHill Biopharma Ltd. - American Depositary Shares (RDHL) as of Q1 2025
As of 31 Mar 2025 RedHill Biopharma Ltd. - American Depositary Shares (RDHL) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,251 shares of stock of the company.
Largest 10 holders included CITADEL ADVISORS LLC, GAMMA Investing LLC, Federation des caisses Desjardins du Quebec, RHUMBLINE ADVISERS, BANK OF AMERICA CORP /DE/, Financial Management Professionals, Inc., GROUP ONE TRADING LLC, MORGAN STANLEY, SBI Securities Co., Ltd., and UBS Group AG.
This table shows 11 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.